Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre

Table 4

Adverse outcomes.

Side effect	Number of patients
Nausea and vomiting	28 (20.7%)
Abdominal pain	8 (5.9%)
Abdominal bloating/flatulence	16 (11.9%)
Constipation or diarrhoea	6 (4.4%)
Gastroesophageal reflux	9 (6.7%)
Erosive gastritis or oesophagitis	2 (1.5%)
Deflation or displacement of IGB	1 (0.7%)
Gastrointestinal obstruction	1 (0.7%)
Premature removal	15 (10.4%)